StonvexLoading…
StonvexStonvexStonvexCore line items from USFD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-27 | Annual 2024 2024-12-28 | Annual 2023 2023-12-30 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $39.42B | $37.88B | $35.60B | $34.06B |
Operating Income | $1.20B | $1.10B | $1.02B | $594.00M |
Net Income | $676.00M | $494.00M | $506.00M | $265.00M |
EPS (Diluted) | $2.94 | $2.02 | $2.02 | $1.01 |
Total Assets | $13.94B | $13.44B | $13.19B | $12.77B |
Total Liabilities | $9.64B | $8.91B | $8.44B | $8.28B |
Cash & Equivalents | $41.00M | $59.00M | $269.00M | $211.00M |
Free Cash Flow OCF − CapEx | $959.00M | $833.00M | $831.00M | $500.00M |
Shares Outstanding | 220.50M | 230.50M | 245.10M | 225.00M |